Servando Cardona-Huerta
Overview
Explore the profile of Servando Cardona-Huerta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
404
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hussain S, Naseem U, Ali M, Avendano Avalos D, Cardona-Huerta S, Bosques Palomo B, et al.
BMC Med Inform Decis Mak
. 2024 Oct;
24(1):310.
PMID: 39444035
Background: Recently, machine learning (ML), deep learning (DL), and natural language processing (NLP) have provided promising results in the free-form radiological reports' classification in the respective medical domain. In order...
2.
Avendano D, Marino M, Bosques-Palomo B, Davila-Zablah Y, Zapata P, Avalos-Montes P, et al.
Insights Imaging
. 2024 Oct;
15(1):244.
PMID: 39387984
Objectives: To validate the performance of Mirai, a mammography-based deep learning model, in predicting breast cancer risk over a 1-5-year period in Mexican women. Methods: This retrospective single-center study included...
3.
Rojas-Zumbado S, Tamez-Pena J, Trevino-Ferrer A, Diaz-Garza C, Ledesma-Hernandez M, Esparza-Sandoval A, et al.
BMC Res Notes
. 2024 Jan;
17(1):30.
PMID: 38243331
Objectives: The data was collected for a cohort study to assess the capability of thermal videos in the detection of SARS-CoV-2. Using this data, a published study applied machine learning...
4.
Zapata-Julian P, Avendano D, Diaz-Perez H, Sofia C, Marino M, Cardona-Huerta S
Radiol Case Rep
. 2023 Oct;
18(12):4345-4350.
PMID: 37789921
Osteosarcoma (OS) of the head and neck is a rare and aggressive disease characterized by the formation of osteoid by malignant osteoblasts. The mandible or maxilla are the most common...
5.
Magallanes-Garza G, Santuario-Facio S, Lira-Albarran S, Varela-Varela A, Cardona-Huerta S, Ruiz-Flores P, et al.
J Oncol
. 2022 Dec;
2022:6001947.
PMID: 36478748
Purpose: To evaluate whether changes in genomic expression that occur beginning with breast cancer (BC) diagnosis and through to tumor resection after neoadjuvant chemotherapy (NCT) reveal biomarkers that can help...
6.
Avendano D, Sofia C, Zapata P, Portaluri A, Orlando A, Avalos P, et al.
Curr Med Imaging
. 2022 Nov;
19(8):799-806.
PMID: 36443968
Breast cancer accounts for 30% of female cancers and is the second leading cause of cancerrelated deaths in women. The rate is rising at 0.4% per year. Early detection is...
7.
Gasca-Sanchez F, Santuario-Facio S, Ortiz-Lopez R, Rojas-Martinez A, Mejia-Velazquez G, Garza-Perez E, et al.
Heliyon
. 2021 Sep;
7(9):e07915.
PMID: 34584999
This research examines the spatial structure of a sample of breast cancer (BC) cases and their spatial interaction with contaminated areas in the Monterrey Metropolitan Area (MMA). By applying spatial...
8.
Ramirez-Galvan Y, Cardona-Huerta S, Elizondo-Riojas G, Montemayor-Martinez A, Morales-Escajeda J, Herrera-Pena C
Ecancermedicalscience
. 2021 Sep;
15:1272.
PMID: 34567257
The screening breast cancer detection rate in Mexico is low. The main objective of this study was to determine the breast cancer detection rate in a Mexican population that attended...
9.
Kuemmel S, Tondini C, Abraham J, Nowecki Z, Itrych B, Hitre E, et al.
Breast Cancer Res Treat
. 2021 Mar;
187(2):467-476.
PMID: 33748921
Purpose: Intravenous trastuzumab, pertuzumab, and docetaxel are first-line standard of care for patients with HER2-positive metastatic breast cancer (mBC). MetaPHER is the first study assessing the safety and tolerability of...
10.
Magallanes-Garza G, Valdez-Alatorre C, Davila-Gonzalez D, Martinez-Resendez M, Sanchez-Salazar S, Castilleja-Leal F, et al.
Int J Gynaecol Obstet
. 2020 Nov;
152(3):439-441.
PMID: 33152797
No abstract available.